Security key
61559X104
MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX)
CUSIP: 61559X104
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Class A ordinary share, par value $0.0001 per share
- Shares outstanding
- 71,686,928
- Total 13F shares
- 58,588,386
- Share change
- -1,134,433
- Total reported value
- $2,765,378,029
- Put/Call ratio
- 82%
- Reported price per share
- $47.20
- Number of holders
- 129
- Value change
- -$36,637,296
- Number of buys
- 57
- Number of sells
- 78
Security identity
Holder snapshot
Report period
Q2 2025
Institutions
129
Top holders
10
MLTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
MoonLake Immunotherapeutics SEC filings
MoonLake Immunotherapeutics company facts
Broader feeds
Reporting periods
Holder history for CUSIP 61559X104
Recent filing periods:
Ownership snapshot
Top reported holders of MLTX - MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
PRICE T ROWE ASSOCIATES I...
13D/G signal
PRICE T ROWE ASSOCIATES I...
Evidence rows
15
Latest as of
31 Mar 2025
13D/G
13F
Lead comparable stake: 4.7%
13D/G row: PRICE T ROWE ASSOCIATES INC /MD/
Showing 1-6 of 15 holder rows.
Rank 1 holder
PRICE T ROWE ASSOCIATES INC /MD/
13D/G
13F
- Ownership
- 4.7%
- Position
- $117.33M
Rank 2 holder
BVF INC/IL
13F
- Ownership
- 28%
- Position
- $771.68M
Rank 3 holder
Cormorant Asset Management, LP
13F
- Ownership
- 12%
- Position
- $331.87M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
13F
T. Rowe Price Associates, Inc. · Company
|
4.7%
|
$117,334,991
2,974,271 shares
|
-$14,571,725 | 31 Mar 2025 |
| BVF INC/IL |
13F
Company
|
28%
|
$771,682,666
19,751,284 shares
|
— | 31 Mar 2025 |
| Cormorant Asset Management, LP |
13F
Company
|
12%
|
$331,866,480
8,494,151 shares
|
— | 31 Mar 2025 |
| FMR LLC |
13F
Company
|
8.8%
|
$247,196,447
6,327,014 shares
|
— | 31 Mar 2025 |
| Avoro Capital Advisors LLC |
13F
Company
|
3.9%
|
$108,227,807
2,770,100 shares
|
— | 31 Mar 2025 |
| CITADEL ADVISORS LLC |
13F
Company
|
2.1%
|
$57,770,270
1,478,635 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
129
Shares
58,588,386
Rows available
129
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
134
Q2 2025 holders
129
Holder diff
-5
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend